Aft Pharmaceuticals Limited focuses on the Pharmaceutical Rx and OTC market. The company also undertakes drug development activities including clinical trials. AFT Pharmaceuticals distributes pharmaceuticals for a number of overseas principals with a sales from pharmacies and hospitals.

Becoming a substantial holder

AFT Licenses Maxigesic IV in Brazil

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aft Pharmaceuticals (AFP AU)

Becoming a substantial holder

AFT Licenses Maxigesic IV in Brazil

AFT,Massey Ventures,Gilles McIndoe to develop scar treatment

AFT further broadens R&D pipeline with new product candidate

NEW YEAR LETTER TO INVESTORS

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)